Introduction
============

The intestinal immune system is continually exposed to foreign antigens in our diet and from the resident intestinal microflora, and must remain tolerant to these innocuous antigens while maintaining the ability to mount appropriate immune responses to mucosal pathogens.

Large numbers of macrophages and dendritic cells (DCs) are present within the intestinal lamina propria (LP) in the steady state and these cells, through their ability to regulate innate and adaptive immune responses, are essential in maintaining gut homeostasis (for reviews, see the studies by Coombes and Powrie^[@bib1]^ and Rescigno and Di Sabatino^[@bib2]^).

CD103^+^, DCs that represent the dominant DC population in the murine small intestinal LP (SI-LP) and in the draining afferent lymph^[@bib3],\ [@bib4],\ [@bib5],\ [@bib6]^ have a central role in initiating T-cell responses to luminal antigen in the draining mesenteric lymph node (MLN),^[@bib5],\ [@bib7],\ [@bib8]^ and have been implicated in mediating oral tolerance.^[@bib8]^ Murine SI-LP and MLN CD103^+^ DCs in both humans and mice share several unique characteristics including an enhanced ability to induce the gut-homing receptors CC chemokine receptor (CCR)9 and α4β7 on responding T cells and naive CD4^+^ T-cell conversion to inducible regulatory T cells, both of which are dependent on signaling events initiated by the vitamin A metabolite, retinoic acid (RA).^[@bib3],\ [@bib5],\ [@bib7],\ [@bib9],\ [@bib10],\ [@bib11]^

Vitamin A (retinol) is obtained through diet and is converted by small intestinal enterocytes to retinyl esters before being transported in chylomicrons through the lymph into the bloodstream. Circulating chylomicron remnants are taken up by stellate cells in the liver, which represents the major storage site of retinol in the body. Retinol, in complex with the retinol-binding protein (RBP)-4, is continually released from the liver into the circulation, and once in tissues, is converted into its active metabolite RA through a two-step enzymatic oxidation (for review, see the study by Blomhoff and Blomhoff^[@bib12]^). Conversion of retinol to retinal is mediated by alcohol dehydrogenases, and retinal is irreversibly converted to RA by retinaldehyde dehydrogenases, the major isoform of which, retinaldehyde dehydrogenase-2, is encoded by *aldh1a2*.^[@bib12]^ SI-LP and MLN CD103^+^ DCs display higher aldehyde dehydrogenase activity, *aldh1a2* expression, and induce enhanced RA signaling in T cells compared with DCs outside the small intestine (SI).^[@bib5],\ [@bib7],\ [@bib13],\ [@bib14]^ Thus, the ability of SI CD103^+^ DCs to efficiently induce gut-homing receptors and inducible regulatory T-cell differentiation, both properties of small intestinal immune responses, seems to be due, at least in part, to their enhanced ability to metabolize retinol.

We, along with others, have suggested that the SI environment modulates the phenotype and activity of SI-LP DCs or their precursors and imprints them with an enhanced ability to metabolize retinal.^[@bib1],\ [@bib5],\ [@bib15],\ [@bib16],\ [@bib17],\ [@bib18],\ [@bib19],\ [@bib20]^ Although several factors induce *aldh1a2* expression and/or aldehyde dehydrogenase activity in DCs *in vitro* including peroxisome proliferator-activated receptor-γ agonists,^[@bib21]^ toll-like receptor-2 ligands,^[@bib22]^ interleukin (IL)-4,^[@bib14],\ [@bib23]^ IL-13,^[@bib14]^ granulocyte macrophage colony-stimulating factor,^[@bib14]^ and RA itself,^[@bib10],\ [@bib14]^ the relevance of these signals in steady-state imprinting of SI-LP CD103^+^ DCs *in vivo* remains unclear. Thus, SI-LP DCs from Myd88^−/−^ and IL-4Rα^−/−^ mice express normal levels of *aldh1a2* and aldehyde dehydrogenase activity.^[@bib13],\ [@bib24]^ Moreover, although total CD11c^+^ cells from the MLN of β-C^−/−^ (a common subunit in the granulocyte macrophage colony-stimulating factor, IL-3, and IL-5 receptor) mice show reduced aldehyde dehydrogenase activity,^[@bib14]^ subsequent studies have shown a central role for granulocyte macrophage colony-stimulating factor in the development of CD103^+^ DCs.^[@bib24],\ [@bib25]^ Recently, CD11c^+^ MLN cells in vitamin A-deficient (VAD) mice^[@bib14]^ were shown to display reduced *aldh1a2* expression and aldehyde dehydrogenase activity, implicating a possible role for retinol itself in DC imprinting. However, it remains unclear whether these effects were due to reduced local imprinting of CD103^+^ SI-LP DCs, and if so, how retinol contributes to the selective imprinting of cells in the SI.

In the current study, we identify a critical role for vitamin A in the local imprinting of SI-LP CD103^+^ DCs. Strikingly, such imprinting did not require dietary intake of retinol. Rather, we demonstrate that the liver releases high levels of retinol into the bile and that bile induces RA receptor (RAR)-dependent retinol-metabolizing activity in DCs and imprints them with the ability to generate gut-tropic T cells.

Results
=======

Vitamin A is essential for the generation of gut-tropic CD8^+^ T cells *in vivo*
--------------------------------------------------------------------------------

Vitamin A is required for DC-induced generation of gut-tropic T cells *in vitro*.^[@bib27],\ [@bib28]^ To determine the role of vitamin A in the generation of gut-tropic effector CD8^+^ T cells *in vivo*, carboxyfluorescein-labeled OT-I cells were transferred into mice maintained on a VAD diet from embryonic day 11 (long-term VAD) or control mice. The vitamin A status of animals was tracked by assessing serum levels of RBP-4 by enzyme-linked immunosorbent assay (ELISA) (Supplementary Figure 1 online). Three days after oral administration of ovalbumin (OVA), OT-I cells in the MLN of long-term VAD and control mice had proliferated extensively; however, CCR9 and α4β7 were only induced on MLN-primed OT-I cells in control mice ([Figure 1a and b](#fig1){ref-type="fig"}). As expected from these results, OT-I cells efficiently localized to the SI epithelium of control but not to that of long-term VAD mice ([Figure 1c](#fig1){ref-type="fig"}). To determine whether CD8^+^ T cells receive RA signals when primed in the MLN, CD8^+^ T cells from OT-I.DR5 mice, which express luciferase under control of three RA-responsive (DR5) elements,^[@bib27]^ were adoptively transferred into control or long-term VAD mice. OVA and lipopolysaccharide were administered intraperitoneally to allow simultaneous T-cell priming in the spleen and MLN, and 1 day later, mice received FTY720 to prevent OT-I.DR5 cell egress from secondary lymphoid organs. Three days after immunization, OT-I.DR5 cells were sorted from the MLN and spleen and assayed for luciferase activity. OT-I.DR5 cells activated in the MLN of control mice displayed significantly enhanced luciferase activity compared with those activated in the spleen ([Figure 1d](#fig1){ref-type="fig"}). Importantly, luciferase activity was absent from OT-I.DR5 cells activated in the MLN of long-term VAD mice, confirming the RAR specificity of the transgene. Taken together, these results demonstrate a critical role for vitamin A in the generation of gut-tropic effector CD8^+^ T cells *in vivo* and also show that CD8^+^ T cells receive enhanced RA signals when primed in the MLN compared with the spleen.

Induction of gut-homing receptors by MLN DCs *in vitro* requires metabolism of serum-derived retinoids
------------------------------------------------------------------------------------------------------

Although MLN DCs induce RA signals and RA-dependent CCR9 induction in responding T cells *in vitro*,^[@bib26],\ [@bib27]^ it remains unclear whether the source of RA in these cultures derives from DC metabolism of retinoids present in fetal calf serum (FCS), or as recently suggested,^[@bib28]^ whether MLN DCs pick up RA in the intestinal mucosa and this carriage of RA is sufficient to induce CCR9 on T cells. To assess these possibilities, MLN DCs were pulsed with OVA peptide and cultured together with carboxyfluorescein-labeled OT-I cells in X-VIVO10 medium, which supports lymphocyte culture in the absence of FCS ([Figure 2a](#fig2){ref-type="fig"}). Although OT-I cells primed in the R10 medium or in the X-VIVO10 medium with 10% FCS were induced to express gut-homing receptors, OT-I cells primed in the X-VIVO10 medium without FCS failed to express CCR9 and α4β7 ([Figure 2a](#fig2){ref-type="fig"}, data not shown). Thus, factor(s) in FCS are required for MLN DCs to induce gut-homing receptors on responding T cells *in vitro*. To determine whether the lack of CCR9 induction in the X-VIVO10 medium was due to a lack of retinol/retinal in these cultures, two different culture assays were set up. In the first assay, retinoids were destroyed in FCS by ultraviolet irradiation^[@bib29]^ before addition to the medium, and under these conditions, CCR9 induction by MLN DCs was abrogated ([Figure 2b](#fig2){ref-type="fig"}). In the second assay, retinal alone was added to the X-VIVO10 cultures, and this resulted in the induction of CCR9 on responding OT-I cells ([Figure 2b](#fig2){ref-type="fig"}). Taken together, these results demonstrate that DC metabolism of retinal to RA, and not carriage of RA from the mucosa, underlies the ability of MLN DCs to generate gut-homing T cells *in vitro*.

Imprinting of SI-LP CD103^+^ DCs is dependent on vitamin A
----------------------------------------------------------

A recent study by Yokota *et al.*^[@bib14]^ demonstrated that total CD11c^+^ MLN cells from long-term VAD mice display reduced *aldh1a2* expression and aldehyde dehydrogenase activity, indicating that vitamin A may have a potential role in regulating the ability of MLN DCs to metabolize retinol. To assess whether these findings extend to CD103^+^ MLN DCs, we examined *aldh1a2* expression and aldehyde dehydrogenase activity in CD103^+^ and CD103^−^ MLN DCs of long-term VAD and control mice. Although the total number and percentage of CD103^+^ DCs in the MLN of long-term VAD mice remained unchanged compared with control mice (Supplementary Figure 2 online), CD103^+^ MLN DCs from long-term VAD mice displayed a striking reduction in *aldh1a2* expression and aldehyde dehydrogenase activity compared with CD103^+^ MLN DCs from control mice ([Figure 3a and b](#fig3){ref-type="fig"}). Aldehyde dehydrogenase activity and *aldh1a2* expression was also dramatically reduced in SI-LP CD103^+^ DCs of long-term VAD mice along the entire length of the SI ([Figure 3c](#fig3){ref-type="fig"}, data not shown). Although colonic CD103^+^ LP DCs also displayed vitamin A-dependent retinol-metabolizing activity, *aldh1a2* expression and aldehyde dehydrogenase activity was far lower in these cells compared with SI-LP CD103^+^ DCs ([Figure 3c](#fig3){ref-type="fig"}, data not shown), consistent with their inability to induce CCR9 on effector T cells *in vitro*.^[@bib5]^

Importantly, pre-DCs, that are the major precursors of SI-LP CD103^+^ DCs^[@bib24]^ as well as all major LN-resident DCs,^[@bib30],\ [@bib31]^ did not display aldehyde dehydrogenase activity (Supplementary Figure 3 online, data not shown). Collectively, these results demonstrate a critical and local role for vitamin A in imprinting CD103^+^ DCs with retinol-metabolizing activity in the SI.

RA signaling is observed in SI-LP CD103^+^ DCs in the steady state and induces retinol-metabolizing activity in DCs *in vitro* and *in vivo*
--------------------------------------------------------------------------------------------------------------------------------------------

As RA represents the major active metabolite of vitamin A, we next assessed whether RA may directly induce retinol-metabolizing activity in DCs. RA induced a significant increase in *aldh1a2* expression and aldehyde dehydrogenase activity in bone marrow-derived (BM)-DCs and imprinted these cells with an ability to generate CCR9^+^ effector T cells ([Figure 4a--c](#fig4){ref-type="fig"} and Supplementary Figure 4 online). To determine whether intestinal CD103^+^ DCs receive RA signals *in vivo*, SI-LP and colonic CD103^+^ DCs were isolated from DR5 reporter mice and luciferase activity assessed by real-time PCR. SI-LP CD103^+^ DCs constitutively expressed luciferase at significantly higher levels than did colonic CD103^+^ DCs ([Figure 4d](#fig4){ref-type="fig"}). Taken together, these results demonstrate that RA can have a direct role in imprinting DCs with the ability to metabolize retinol and that SI-LP CD103^+^ DCs receive enhanced RA signaling compared with colonic CD103^+^ DCs in the steady state.

To assess whether the reduced imprinting of colonic compared with SI-LP CD103^+^ DCs might be due to a reduced ability of colonic CD103^+^ DCs to respond to RA, or to reduced retinoid levels in the colon vs. the SI, we first assessed RAR expression in intestinal CD103^+^ DCs. RARα and RARγ expression was comparable in SI-LP and colonic CD103^+^ DCs ([Figure 5a](#fig5){ref-type="fig"}), whereas RARβ was barely detectable. In contrast, analysis of retinol/retinal levels in a range of intestinal and extra-intestinal tissues demonstrated significantly higher concentrations of retinol and retinal in the SI and draining MLN than in the colon ([Figure 5b](#fig5){ref-type="fig"}, data not shown). Collectively, these results suggested that enhanced levels of the RA precursors, and not selective responsiveness of SI-LP CD103^+^ DCs to RA, underlie the selective imprinting of SI-LP CD103^+^DCs. To determine whether the availability of RA is a potential rate-limiting factor in imprinting colonic CD103^+^ DCs, RA was administered intra-rectally into C57BL/6 mice. Administration of RA induced a significant increase in aldehyde dehydrogenase activity in colonic CD103^+^ DCs ([Figure 5c](#fig5){ref-type="fig"}), indicating that local RA levels are one factor regulating the imprinting of DCs *in vivo*. Notably, the percentage of colonic CD103^+^ DCs expressing aldehyde dehydrogenase activity after RA treatment failed to reach levels found in SI CD103^+^ DCs of control mice, suggesting that other factors in the SI may synergize with RA to enhance the activity of SI CD103^+^ DCs. However, we cannot rule out the possibility that the concentrations of RA used and administration regime for intra-rectal delivery were suboptimal for colonic CD103^+^ DC imprinting. Taken together, these data demonstrate that RA can directly induce retinol-metabolizing activity in DCs and suggest that the high retinol/retinal levels in the SI at least partially underlie selective imprinting of CD103^+^ DCs at this site.

Dietary vitamin A is not required for imprinting SI-LP CD103^+^ DCs with retinol-metabolizing activity
------------------------------------------------------------------------------------------------------

As vitamin A is obtained through diet and the SI and MLN contained significantly higher retinol and retinal levels than did other tissues outside the liver ([Figure 5b](#fig5){ref-type="fig"} and data not shown), we hypothesized that dietary vitamin A was critical for the selective imprinting of SI-LP CD103^+^ DCs. To address this possibility, 5--7-week-old mice were transferred to a VAD or maintained on a conventional diet for 4 weeks (4-week VAD). This time period is too short to effect liver stores or systemic levels of retinol; however, it is sufficiently long enough to allow a complete turnover of the epithelial and SI-LP CD103^+^ DC compartment in the absence of dietary retinol.^[@bib5],\ [@bib32]^ Mice kept on a 4-week VAD diet showed a marked reduction in retinol levels in the MLN, whereas retinol levels in the liver, spleen, peripheral lymph nodes (LNs), and serum remained unchanged ([Figures 6a](#fig6){ref-type="fig"} and [7b](#fig7){ref-type="fig"}), thus demonstrating that dietary retinol accounts for much of the enhanced retinol levels observed in the MLN. Strikingly, under these conditions, MLN CD103^+^ DCs still expressed high levels of *aldh1a2* and aldehyde dehydrogenase activity, whereas aldehyde dehydrogenase activity in SI-LP CD103^+^ DCs was only partially reduced ([Figure 6b--d](#fig6){ref-type="fig"}). Taken together, these results demonstrate that dietary retinol intake, although likely contributing to DC imprinting in the steady state, is not essential to maintain selective imprinting of SI-LP CD103^+^ DCs.

Bile contains high levels of retinol and imprints DCs with the ability to generate gut-tropic effector T cells
--------------------------------------------------------------------------------------------------------------

Despite the reduction of retinol in the MLN of 4-week VAD mice, retinol levels remained significantly higher than in other tissues, indicating that even in the absence of dietary vitamin A, the SI mucosa may receive additional sources of retinol ([Figure 6a](#fig6){ref-type="fig"}). Consistent with this possibility, SI-LP CD103^+^ DCs from DR5 mice maintained on a 4-week VAD diet continued to receive enhanced RA signals compared with colonic CD103^+^ DCs ([Figure 7a](#fig7){ref-type="fig"}). Notably, the liver, the retinol levels of which remained unchanged in 4-week VAD mice ([Figure 6a](#fig6){ref-type="fig"}), is also the source of bile acids that have an essential role in emulsifying dietary fats and fat-soluble vitamins in the SI. Bile drains from the liver through the gall bladder and the common bile duct into the duodenum, with the majority of bile salts being recycled after re-absorption in the ileum through the entero-hepatic circulation. As retinoids have been reported to be present in the bile of guinea pigs, rats, and chicks,^[@bib33],\ [@bib34],\ [@bib35],\ [@bib36]^ we hypothesized that the selective imprinting of CD103^+^ DCs in the SI may result from the continual supply of retinol and its derivatives from the liver through the bile. Consistent with this hypothesis, retinol levels in the bile of mice kept on a conventional or a 4-week VAD diet were significantly higher than in the serum ([Figure 7b](#fig7){ref-type="fig"}). To assess whether bile induces RA signaling, BM-DCs from DR5 mice were incubated with 0.5% bile, and luciferase activity was assessed 2 days later ([Figure 7c](#fig7){ref-type="fig"}). This concentration of bile did not affect the total number or viability of BM-DCs in the cultures as assessed by flow cytometry (data not shown). Bile from mice maintained on a conventional but not long-term VAD diet induced luciferase expression in BM-DCs ([Figure 7c](#fig7){ref-type="fig"}, data not shown). Importantly, bile from mice maintained on a conventional or 4-week VAD diet induced aldehyde dehydrogenase activity and *aldh1a2* expression in BM-DCs ([Figure 7d--e](#fig7){ref-type="fig"} and Supplementary Figure 4a online), which was dependent on RA signaling as it was blocked by the pan-RAR inhibitor, LE540. Finally to determine whether bile-conditioned DCs could generate CCR9^+^ effector T cells, DCs were incubated with bile in the presence/absence of LE540, washed, pulsed with OVA, and incubated with OT-I cells. BM-DCs conditioned with bile or 4-week VAD bile induced CCR9 on responding OT-I cells, whereas OT-I cells primed by BM-DCs that had been conditioned with bile in the presence of LE540 failed to express CCR9 ([Figure 7f](#fig7){ref-type="fig"} and Supplementary Figure 4b online). Collectively, these results indicate that in the absence of dietary vitamin A, bile-derived retinoids contribute to the selective imprinting of SI-LP CD103^+^ DCs.

Discussion
==========

CD103^+^ DCs are the major migratory DC population in the SI and have a central role in initiating immune responses to luminal antigen in draining MLN. Both SI-LP and MLN CD103^+^ DCs are imprinted with the ability to metabolize retinol, a property that underlies their enhanced capacity to generate gut-homing effector T cells and induce FoxP3^+^ T-cell differentiation.^[@bib3],\ [@bib6],\ [@bib8],\ [@bib10],\ [@bib11],\ [@bib12]^ In this study, we demonstrate that imprinting of SI-LP CD103^+^ DCs occurs locally in the SI mucosa and is critically dependent on vitamin A. Our results further show that dietary vitamin A is not essential for imprinting and suggest a role for liver-derived bile retinoids in the selective imprinting of CD103^+^ DCs.

A recent study by Feng *et al.*,^[@bib37]^ based primarily on *in vitro* work, suggested that RA induces CCR9 expression and retinol-metabolizing activity on DCs in the bone marrow thus generating a specific intestinal homing DC subset. Although our results also demonstrate a critical role for vitamin A in the generation of retinol-metabolizing SI-LP CD103^+^ DCs, they strongly argue against this model. Thus, we found that the number of CD103^+^ MLN DCs was not reduced in long-term VAD mice, as might be expected if RA was required for CCR9-dependent recruitment of DCs into the SI. Indeed, in CCR9 KO mice, SI-LP and MLN CD103^+^ DCs are found in normal numbers and display comparable aldehyde dehydrogenase activity to that observed in wild-type mice (K.K., unpublished observation). Second, using RA-responsive element (DR5) reporter mice, we show that CD103^+^ DCs constitutively receive RA signals in the SI and at significantly higher levels than in the colon. Most importantly, we demonstrate that pre-DCs in the SI-LP, which are the major precursors of SI-LP CD103^+^ DCs,^[@bib25]^ lack retinol-metabolizing activity. Collectively, these results strongly indicate that RA functions locally within the SI to imprint CD103^+^ DCs. Although we provide *in vitro* evidence that RA can directly imprint DCs with retinol-metabolizing activity, our results do not exclude that potential indirect effects of RA may contribute to SI-LP CD103^+^ DCs imprinting *in vivo*; nor can we rule out that indirect effects of VAD deficiency may contribute to the block in DC imprinting observed in these mice.

A striking observation made from the current study was that SI-LP CD103^+^ DCs isolated from mice deprived of dietary retinol, but with normal systemic retinol levels, still received high RA signals and remained imprinted with retinol-metabolizing activity. Bile drains from the liver through the gall bladder and common bile duct into the duodenum. In this study, we show that bile from conventionally fed and 4-week VAD mice also contains retinol and at significantly higher concentrations than found in serum and other tissues (outside the liver). Importantly, bile from these mice induced RA signals in DCs and imprinted them with retinol-metabolizing activity and the ability to generate gut-tropic effector T cells. These results strongly suggest that liver-derived retinol and its metabolites are transported through the bile, bathing the SI, where they contribute to SI-LP CD103^+^ DC imprinting. Although the current study focused on the role of vitamin A in imprinting CD103^+^ DCs, two recent studies have demonstrated that MLN but not peripheral LN stromal cells also possess the enzymatic machinery to generate RA, and thus may contribute to gut-tropic T-cell generation in the MLN *in vivo*.^[@bib38],\ [@bib39]^ Thus, it will be of interest to determine whether dietary and/or bile-derived retinoids are also involved in the selective imprinting of MLN stromal cells.

Several previous studies have suggested a central role for bile constituents in maintaining intestinal immune homeostasis. For example, mice deficient in the major bile acid farnesoid X receptor show increased bacterial counts and disturbed epithelial barrier function in the ileum,^[@bib40]^ increased proinflammatory cytokines in the colon, and exacerbated inflammation in 2,4,6 trinitrobenzene sulfonic acid (TNBS) colitis.^[@bib41]^ Furthermore, farnesoid X receptor ligands repress lipopolysaccharide-induced inflammatory cytokine expression in intestinal LP macrophages.^[@bib41]^ Both farnesoid X receptor and RAR form a heterodimer with RXR to function as ligand-induced transcription factors bound to DNA target genes. In this regard, it will be of considerable interest to determine the functional interplay between bile-induced farnesoid X receptor-/RXR and RAR/RXR signaling in the modulation of SI-LP CD103^+^ DC function.

In summary, our results describe a novel role for vitamin A and bile in local imprinting of SI-LP CD103^+^ DCs, and thus in shaping the unique characteristic of SI immune responses.

Methods
=======

**Mice.** C57BL/6, C57BL/6.CD45.1, OT-1, OT-I.CD45.1, DR5, and DR5.OT-I mice^[@bib27]^ were bred and maintained at the Biomedical Center Animal Facility (Lund University, Sweden). Mice were used between 6 and 14 weeks of age. Long-term VAD mice were generated by placing pregnant mice on a VAD diet (TD88407, Harlan Laboratories, Madison, WI) starting at day 11 of gestation, and pups were maintained on this diet until at least 8 weeks of age. Vitamin A deficiency was confirmed by analyzing serum levels of RBP-4 by ELISA or liver retinol levels upon killing. Protocols for the ELISA and quantitation of retinol are described below. Control mice were maintained on a vitamin A-sufficient diet (TD08536, Harlan Laboratories). For generating 4-week-VAD mice, 5--7-week-old littermates were placed on a VAD (TD88407) or a vitamin A-sufficient diet (TD08536) for 4 weeks. For *in vivo* RA administration, anesthetized animals were injected intra-rectally with RA (10 μ) or vehicle (dimethyl sulfoxide) in phosphate-buffered saline (PBS) 64, 40, 26, and 16 h before the killing. All animal experiments were performed after obtaining approval from the Lund/Malmö Animal Ethics Committee.

**Antibodies and reagents.** The following antibodies were used for flow cytometry: PE or bio-CD103 (M290), PE-α4β7 (DATK32), APC-CD11c (N418), PE or bio-rat IgG2a (RG7/1.30), bio-IgG2b isotype, bio-rat IgG2b (G15-337), streptavidin-PE, streptavidin-PECy7, PE-CD45.1 (A20), PE-Cy7-CD45 (Ly-5), streptavidin-APC, bio-CD8β (53--5.8), PE-Vβ 5.1.5.2 (MR9-4) (all obtained from BD Biosciences, Franklin Lakes, NJ); Alexa700-CD11c (N418), Pacific Blue-MHC Class II (M5/114.15.2), Alexa700-CD45.1 (A20) (all obtained from BioLegend, San Diego, CA); PE and APC-A750-CD45.2 (104), APC-Vα2 (B20.1), and Pacific Blue-CD8α (53--6.7) (all purchased from eBioscience, San Diego, CA); streptavidin-QD605 (Invitrogen, Carlsbad, CA); anti-FcRII/III (2.4G2) and anti-CCR9 antibody (7E7, kind gift from O. Pabst^[@bib42]^) were purified from hybridomas. The OT-I peptide (SIINFEKL) was obtained from Innovagen, Lund, Sweden. OVA grade VII, DNase I, collagenase type IV and VIII, and lipopolysaccharide (*Escherichia coli*, serotype 055:B5) were from Sigma-Aldrich, St Louis, MO. FTY720 was obtained from Cayman Chemical, Ann Arbor, MI. The X-VIVO10 medium was from Cambrex (Walkersville, MD).

**Cell isolation.** Cells were prepared from the SI and colon as described previously.^[@bib5]^ In brief, the intestinal tissue was rinsed, Peyer\'s patches and fat were excised, and the tissue was cut open longitudinally and into ∼0.5 cm pieces. Tissue pieces were incubated with 2 m EDTA to remove the epithelium and intraepithelial lymphocytes. Intraepithelial lymphocytes were enriched from this fraction on a 40:70% percoll gradient. SI-LP DCs were isolated from remaining tissue pieces by collagenase VIII (250 μg/ml) digestion in the presence of CaCl~2~ (50 m). Where indicated, SI was divided into the duodenum (first 2.5 cm after the pylorus), the ileum (distal 4 cm of the SI), and the remaining jejunum was divided equally into two portions, the proximal and the distal jejunum. For isolation of LNT cells and DCs, LNs were cut and filtered directly through a 70-mm cell strainer or incubated with collagenase IV (500 μg/ml) and DNAse I (50 Units/ml) for 30 min at 37°C before filtering, respectively. CD8β^+^ cells were enriched to \>85% purity using bio-anti-CD8β (53--5.8), followed by streptavidin-conjugated MACS beads (Miltenyi Biotech, Bergisch Gladbach, Germany).

**Cell purification and flow cytometry.** DCs were sorted directly (LP preparations) or enriched using anti-CD11c-conjugated MACS beads (Miltenyi Biotech) (LN preparations) before sorting. Dead cells were excluded using 7-amino-actinomycin D (Sigma-Aldrich) or propidium iodide (Invitrogen). Sorted DC fractions were routinely 95--99% pure. Flow cytometry analysis was performed using FACSAria, FACSCalibur, or FACS LSRII (BD Biosciences) and analyzed using FlowJo software (Tree Star, Ashland, OR). Reagents used for flow cytometry are described in the online Supplementary Materials online.

**Adoptive transfers.** Carboxyfluorescein-labeled OT-I or OT-I.DR5 CD8β^+^ T cells were injected intravenously (3--5 × 10^6^ per mouse) into C57BL/6 mice. One day later, mice received OVA by gavage (50 mg) or by intraperitoneal injection (5 mg). Where indicated, mice received lipopolysaccharide intraperitoneally (25 μg) together with OVA and/or FTY720 (20 μg, intraperitoneally) 24 h after OVA administration.

**BM-DCs.** BM-DCs were generated as described previously.^[@bib43]^ For determinations of RA signaling, day 9 BM-DCs from DR5 mice (2.5 × 10^5^) were seeded into 24-well ultra-low attachment plates (Costar-Corning, Amsterdam, Netherlands) and incubated as indicated for 2 days. Luciferase activity was determined using the luciferase assay system kit (Promega, Madison, WI) and a Glomax luminometer (Promega) according to the manufacturer\'s instructions. For ALDEFLUOR measurements, day 6 BM-DC cultures were incubated with RA or bile as indicated for 2 days and then analyzed by flow cytometry as described below. Live MHCII^+^CD11c^+^ cells were sorted from the same cultures for PCR analysis. RA or bile at the concentrations used had no significant effect on the total number or proportion of MHCII^+^CD11c^+^ cells in these cultures, or on the expression levels of MHCII (data not shown).

***In vitro* DC-T-cell cultures.** MLN DCs or day 8 BM-DCs were pulsed with OVA for 2 h at 37°C, washed extensively, and incubated with OT-I cells in flat bottom 96-well plates (Thermo Fisher Scientific, Waltham, MA) in 250 μl R10 media at a 1:2 ratio (2.5 × 10^4^ DCs with 5 × 10^4^ T cells). Responding OT-I cells were analyzed after 3.5 day by flow cytometry.

**Retinol measurements.** Tissues were weighed and stored at −80°C before analysis. For bile collection, the gallbladder was removed, placed in an Eppendorf tube, and punctured with a 30-G needle. The gallbladder was fixed with one edge between the tube and the lid, and centrifuged for 1 min at 20,000 g. Bile was stored at −20°C before analysis. Tissues were homogenized in ice-cold PBS using a motorized homogenizer (Pellet grinder, Kontes, Vineland, NJ). Retinoids were extracted from the tissue homogenate by adding 2 volumes of ice-cold acetonitrile (containing a ^13^C-labeled stable isotope of atRA as the internal standard) per volume of tissue homogenate (e.g., 200 mg tissue homogenate; 400 μl acetonitrile) shaken for 15 min in an orbital shaker and centrifuged (10 min, 10°C, 2,700 g). The entire procedure was performed under red light. An aliquot of 75 μl was injected into a 4000 Q-TRAP LC-MS/MS, triple quadrupole mass spectrometer with APCI ionization (Applied Biosystems, Foster City, CA). Chromatographic analysis and mass spectrometric conditions were as described previously,^[@bib44]^ except that the separating column was a Supelco ABZ Plus, 70 × 3 mm^2^ ID, 3 μm particles (Supelco, Bellefonte, PA).

**Mouse RBP-4 ELISA.** ELISA plates (Maxisorb, NUNC, Roskilde, Denmark) were coated overnight with serum (1:1,666 to 1:5,000) or recombinant mouse RBP-4 (1:500 to 1:1,66,000, R&D Systems, Minneapolis, MN) diluted in PBS. Plates were blocked with blocking buffer (PBS and 1% bovine serum albumin) for 1 h at room temperature, washed with PBS and 0.05% Tween20, and incubated with biotinylated sheep anti-mouse RBP-4 (0.5 mg/ml, R&D Systems) in blocking buffer for 1.5 h at room temperature. After washing, streptavidin-coupled peroxidase (1:4,000, BioLegend) was applied and plates incubated for 45 min at room temperature. BD OptEIA TMB Substrate Reagent Set (BD Bioscience) was used for color development, the reaction stopped with 2 N sulfuric acid and absorbance was measured at 450 nm using a Emax plate reader (Molecular Devices, Sunnyvale, CA).

**Real-time PCR.** Total RNA was isolated from sorted cells using the RNeasy Micro Kit (Stratagene, Santa Clara, CA). cDNA was generated using Superscript III First-Strand Kit (Invitrogen) with both random hexamers and pT-primer present and used as a template for quantitative real-time PCR. Quantitative PCR was performed on a MyiQ Single-Color Real-Time PCR Detection System (Bio-Rad, Hercules, CA), using the Power Sybr Green PCR Master Mix (Applied Biosystems, Warrington, UK) or SsoFAST EvaGreen SuperMix (Bio-Rad) according to the manufacturer\'s instructions. The following primers were used: *aldh1a2* forward 5′CAGATGCTGACTTGGACTAC3′ *aldh1a2* reverse 5′ATAAGCTCCAGGACTTTGTT3′ *β-actin* forward *5*′CCGGGACCTGACAGACTA3′ *β-actin* reverse 5′GTTTCATGGATGCCACAGGAT3′ *RARα* forward 5′CGAATCTGCACGCGGTACACGCCT3′ *RARα* reverse 5′GTGCTTCCAGCAGCGGCTCTTG3′ *RARβ* forward 5′ACTGACCTTGTGTTCACCTTTGCCA3′ *RARβ* reverse 5′GGTCGTCGTTTTCTAATGTAAATCT3′ *RARγ* forward 5′CAGTATGTAGGAGGGACTCTCTGCA3′ *RARγ* reverse 5′TCCTTGGGGAGGTCAGGCTGGCCC3′ *firefly luciferase* forward 5′CGTTCGTCACATCTCATCTCATCTACCTC3′ *firefly luciferase* reverse 5′CCACATATCAAATATCCGAGTGT3′ and *RDH10* forward 5′GTTTCTGGACATCACCTTCT3′ *RDH10* reverse 5′GTAATCCTCAACTCCAGCA3′. For [Figure 7a](#fig7){ref-type="fig"}, samples were first amplified for 12 cycles by PCR using the following primers: *β-actin* forward 5′CCGGGACCTGACAGACTA3′ *β-actin* reverse 5′ACGGATGTCAACGTCACACTTC3′ and *firefly luciferase* forward 5′CAGTCGATGTACACGTTCGTCAC3′ *firefly luciferase* reverse 5′CCACATATCAAATATCCGAGTGT3′. For subsequent quantification by nested PCR, the following primers were used: *β-actin* forward 5′GAGAGGGAAATCGTGCGTGAC3′ *β-actin* reverse 5′GTTTCATGGATGCCACAGGAT3′ and *firefly luciferase* forward 5′CGTTCGTCACATCTCATCTCATCTACCTC3′ *firefly luciferase* reverse 5′CCACATATCAAATATCCGAGTGT3′.

The expression of all genes was normalized to *β-actin*.

**Aldehyde dehydrogenase activity.** Aldehyde dehydrogenase activity was determined using the ALDEFLOUR staining kit (StemCell Technologies, Grenoble, France) according to the manufacturer\'s instructions and as described previously.^[@bib6]^

**Statistical analysis.** Statistical analyses were performed using GraphPad Prism software (GraphPad, La Jolla, CA) using paired or unpaired two-tailed Student\'s *t*-test or ANOVA (analysis of variance), followed by Newman--Keuls post-test. Error bars represent s.d.
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![Vitamin A is essential for induction of CC chemokine receptor (CCR)9 and α4β7 on activated T lymphocytes *in vivo*. (**a**--**c**) OT-I.CD45.1 cells were adoptively transferred into CD45.2 long-term vitamin A-deficient (VAD) mice or control mice. (**a**) CFSE dilution and (**b**) CCR9 and α4β7 expression on responding OT-I cells in the mesenteric lymph node (MLN) of mice kept on a conventional (white bar) or long-term VAD (black bar) diet 3 days after oral ovalbumin (OVA) administration. Results are (**a**) representative FACS plots from three experiments with two to three mice per group per experiment and (**b**) mean (s.d.) of four experiments with two to three mice per group per experiment. (**c**) FACS plots of CD8^+^ intraepithelial lymphocytes in long-term VAD and control mice 3 days after OVA administration. Representative results from one experiment of three with two to three mice per group per experiment. (**d**) DR5.OT-I cells were adoptively transferred into CD45.1 long-term VAD or control mice. OVA and LPS were injected i.p., and 1 day later, mice received FTY720 to prevent OT-I.DR5 cell egress from secondary lymphoid organs. OT-I cells were sorted 3 days after immunization and assessed for luciferase activity. Results are the mean (s.d.) of three experiments, two to four mice per group per experiment. CFSE, carboxyfluorescein; FACS, fluorescence-activated cell sorting; i.p., intraperitoneal; LPS, lipopolysaccharide; RLU, relative luciferase units.](mi201091f1){#fig1}

![Induction of chemokine receptor (CCR)9 by mesenteric lymph node (MLN) dendritic cells (DCs) *in vitro* requires metabolism of exogenously derived retinol. (**a**, **b**) DCs were isolated from the MLN, pulsed with the ovalbumin (OVA) peptide (40 n), and cultured together with CFSE-labeled OT-I cells in RPMI or X-VIVO10 media with or without addition of fetal calf serum (FCS), UV-irradiated FCS, or retinal as indicated. CC chemokine receptor (CCR)9 expression on responding OT-I cells was assessed 3 days later. (**a**) Results are representative FACS plots from one experiment of four performed. (**b**) Results are representative FACS plots from one experiment of four (UV irradiated) and three (retinal) performed. CFSE, carboxyfluorescein; UV, ultraviolet.](mi201091f2){#fig2}

![Vitamin A is required for the selective imprinting of CD103^+^ dendritic cells (DCs) along the length of the small intestine (SI). (**a**) CD103^+^ and CD103^−^ DCs were sorted from the mesenteric lymph nodes (MLNs) of long-term vitamin A-deficient (VAD) mice and control mice and assessed for expression of *aldh1a2* by real-time PCR. Mean (s.d.) from five to seven experiments with one to two mice per group per experiment. (**b**, **c**) Aldehyde dehydrogenase (ALDH) activity in (**b**) MLN and (**c**) SI and colonic lamina propria (LP) CD103^+^ DC from control and long-term VAD mice was assessed by flow cytometry in the presence/absence of the ALDH inhibitor diethylaminobenzaldehyde (DEAB). Mean (s.d.) of three to five experiments with one to three mice per group per experiment. Dist, distal; Prox, proximal.](mi201091f3){#fig3}

![Retinoic acid (RA) induces retinol-metabolizing activity in dendritic cells (DCs). (**a**) Bone marrow-derived (BM)-DCs were treated with RA (20 n) for 2 days, and *aldh1a2* expression on sorted CD11c^+^ MHCII^int^ cells was assessed by real-time PCR. Mean (s.d.) of four experiments. (**b**) BM-DCs were incubated with RA as described above, and aldehyde dehydrogenase activity was determined by flow cytometry. Each symbol represents cells from a single well. Data obtained from six separate experiments are shown. (**c**) BM-DCs were incubated with RA (20 n) with/without the RA receptor inhibitor (inh) LE540 (2 μ) for 2 days, pulsed with ovalbumin (OVA), washed and incubated together with OT-I cells. CC chemokine receptor (CCR)9 expression on OT-I cells was assessed 3.5 days later. Symbols are results obtained from independent wells from three different experiments in which each well contained BM-DCs treated separately with RA. (**d**) CD103^+^ DCs were sorted from the lamina propria (LP) of the small intestine (SI) and colon of DR5 mice and assessed for luciferase activity by real-time PCR. Mean (s.d.) of three experiments with sorted cells from two mice per organ per experiment. RAR, RA receptor.](mi201091f4){#fig4}

![Retinol levels are higher in the small intestine (SI) than in the colon and correlate with enhanced RA signaling in the small intestinal lamina propria (SI-LP) CD103^+^ DCs. (**a**) RA receptor (RAR)α and RARγ mRNA levels in sorted SI and colonic CD103^+^ DCs. Mean (s.d.) of three to five experiments with sorted cells from one to two pooled mice per experiment. (**b**) Retinol levels in tissues. Mean (s.d.) of retinol determinations from tissues of eight individual mice. (**c**) RA (filled boxes) or carrier (filled circles, filled triangles) was administered intra-rectally into mice as described in the "Methods" section, and aldehyde dehydrogenase activity in SI and colonic LP CD11b^+^ CD103^+^ DCs was assessed by flow cytometry. Each symbol represents an individual mouse. DC, dendritic cell; MLN, mesenteric lymph node; PLN, peripheral lymph node; RA, retinoic acid; SPL, spleen.](mi201091f5){#fig5}

![Dietary vitamin A is not required for imprinting of small intestinal CD103^+^ dendritic cells (DCs). (**a**) Retinol levels are higher in the mesenteric lymph nodes (MLNs) than in the peripheral lymph nodes (PLN) and spleen of 4-week vitamin A-deficient (VAD) mice. Mean (s.d.) of 4--15 individual mice. (**b**) *Aldh1a2* expression in sorted CD103^+^ MLN DCs from 4-week VAD and control mice was assessed by real-time PCR. Data are obtained from one representative experiment of two performed using two to three pooled mice per group per experiment. (**c**, **d**) Aldehyde dehydrogenase (ALDH) activity in (**c**) MLN and (**d**) small intestinal lamina propria (SI-LP) CD103^+^ DCs from 4-week VAD and control mice was assessed by flow cytometry in the presence/absence of the ALDH inhibitor diethylaminobenzaldehyde (DEAB). Mean (s.d.) of three to five experiments (two experiments for MLN control DEAB) using one to two pooled mice per group per experiment. Dist, distal; n.s., not significant; Prox, proximal.](mi201091f6){#fig6}

![Bile contains high levels of retinol and imprints bone marrow-derived dendritic cells (BM-DCs) with the ability to generate CC chemokine (CCR)9^+^ T cells. (**a**) Luciferase expression in small intestinal lamina propria (SI-LP) and colonic CD103^+^ DCs from DR5 mice kept on a 4-week vitamin A-deficient (VAD) or control diet. Results are the mean (s.d.) of 3 (4-week VAD) or 2 (control diet) independent experiments using pooled SI-LP CD103^+^ DCs from 2 mice per experiment, or from 1 experiment using pooled colonic CD103^+^ DCs from 3 mice. (**b**) Bile and serum retinol levels in control and 4-week VAD mice. Mean (s.d.) of 7--12 individual mice (serum) or from 7--12 samples from 1--3 pooled mice per sample (bile). (**c**) BM-DCs from DR5 mice were incubated for 2 days with retinoic acid (RA) (20 n) or bile (0.5%) with/without the pan RA receptor inhibitor (inh) LE540 (2 μ). Luciferase activity/10^5^ MHCII^+^ CD11c^+^ cells was determined and normalized in each experiment to the control. Each symbol represents a single experiment with separate bile samples per experiment. (**d**) Aldehyde dehydrogenase activity and (**e**) *aldh1a2* expression in CD11c^+^MHCII^int^ BM-DCs after treatment with the indicated compounds. (**d**) Each symbol represents data obtained from individual wells in which BM-DCs were incubated with bile samples from different mice. Data are mean (s.d.) of four to six independent experiments. (**f**) BM-DCs were incubated with bile (0.5%) in the presence or absence of RAR inhibitor (inh) for 2 days, washed, pulsed with ovalbumin (OVA), and incubated together with OT-I cells. CCR9 expression on responding cells was assessed 3.5 days later by flow cytometry. Each symbol represents data from individual wells in which BM-DCs were pre-incubated with bile samples obtained from different mice. Mean (s.d.) of two to three experiments. n.s., not significant.](mi201091f7){#fig7}
